XOFLUZA Granules 2% Individual Packets Specified Drug Use results Survey (Survey of patients weighing less than 10 kg)

XOFLUZA Granules 2% Individual Packets Specified Drug Use results Survey(Survey of patients weighing less than 10 kg) - XOFLUZA Granules Specified Drug Use results Survey(Survey of patients weighing less than 10 kg)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000060194

Enrollment

Registered

2026-01-05

Start date

2026-01-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

influenza A or B virus infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with influenza A or B virus infection weighing less than 10 kg who are receiving baloxavir marboxil for the first time

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Safety in patients weighing less than 10 kg	—

Countries

Japan

Contacts

Public ContactKanae Hara

Shionogi & Co., Ltd. Pharmacovigilance Department

kanae.hara@shionogi.co.jp+81-6-6202-2161

Outcome results